期刊文献+

麻黄碱缩短顺式阿曲库铵起效时间的临床研究 被引量:2

下载PDF
导出
摘要 目的:研究全麻诱导期间麻黄碱缩短顺式阿曲库铵起效时间,增加顺势阿曲库铵临床适用范围。方法:选择ASAⅠ~Ⅱ级病人30例,随机分成两组,对照组采用0.9%氯化钠注射液(5ml),实验组麻黄素70μg/kg(5ml),复合相同静脉麻醉诱导药,意识消失后静脉滴注肌松药顺式阿曲库铵0.15mg/kg,用4个成串刺激(TOF)刺激尺神经,连续监测拇内收肌肌颤搐变化,观察并记录T1完全抑制时间(即肌松药起效时间)。结果:统计学分析两组肌松药起效时间差异有显著性(P<0.05),麻黄碱组气管插管的分数评估较高(P<0.05)。结论:麻黄碱缩短顺式阿曲库铵起效时间,并改善了气管插管的肌松条件,而无循环系统不良作用。
作者 韩彬 郭艳辉
出处 《现代医药卫生》 2009年第5期680-681,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献10

  • 1Moore EW, Hunter JM.The new neuromuscular blocking agents: do they offer any advantages[J].Br J Anaesth,2001,Dec87(6) : 912.
  • 2Atherton DP, Hunter JM.Clinieal pharmacokinetics of the newer neuromuscular blocking drugs[J].Clin Pharmacokinet,1999 Mar,36(3): 169.
  • 3Della Roeca G,Pompei L, Coceia C, et al.Atracurium, eisatraeurium, vecuronium and rocttronium in patients with renal failure[J].Minerva Anestesiol, 2003, Jul-Aug;69(7-8) : 605.
  • 4Sparr HJ,Beaufort TM,Fuchs-Buder T.Newer neuromuscular blocking agents: how do they compare with established agents[J].Drugs, 2001,61(7) :919.
  • 5Kisor DF,Schmith VD,Wargin WA,et al.Importanee of the organindependent elimination of cisatracurium[J].J.Anesth Analg, 1996, Nov83(5) : 1065.
  • 6Cooper R,Mirakhur RK,Clarke RS,et al. Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxam- ethonium[J].Br J Anaesth, 1992,69:269.
  • 7邱郁薇,李士通.非去极化肌松药相互作用的机制及临床应用[J].国际麻醉学与复苏杂志,2007,28(3):250-252. 被引量:9
  • 8Albert F,Hans P,Bitar Y,et al.Effects of ephedrine on the onset time of neuromuscular block and intubating conditions after cisatracurium:preliminary restdts[J].Acta Anaesthesiol Belg,2000,51(3): 167.
  • 9Gamlin F, Vucevic M,Winslow,et al.The haemodynamic effects of propofol in combination with ephedrine[J].Anaesthesia, 1996,51 : 488.
  • 10Kim KS,Cheong MA ,Jeon JW,et al.The dose effect of ephedrine on the onset time of vecuronium[J].Anesth Analg, 2003, Apr96(4) : 1042.

二级参考文献16

  • 1Lee C. Structure, conformation, and action of neuromuscular blocking drugs. Br J Anaesth, 2001,87:755-769.
  • 2Motamed C, Kirov K, Combes X, et al. Interaction between mivacurium and pancuronium: impact of the order of administration. Eur J Clin Pharmacol, 2005,61:175-177.
  • 3Breslin DS, Jiao K, Habib AS, et al. Pharmacodynamic interactions between cisatracurium and rocuronium. Anesth Analg, 2004,98:107- 110.
  • 4Motamed C, Donati F. Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults. Can J Anaesth, 2000,47:225-231.
  • 5Stout RG, Shine TS, Silverman DG, et al. Recovery of neuromuscular function after a combination of mivacurium and rocuronium. Yale J Biol Med, 2004,77:149-154.
  • 6Lien, Cynthia A. Combining non-depolarizing neuromuscular blocking agents: synergism, addition or antagonism? Current Opinion in Anaesthesiology, 1999,12:467-471.
  • 7Nigrovic V, Amann A. Simulation of interaction between two non- depolarizing muscle relaxants: generation of an additive or a supra-additive neuromuscular block. Journal of Pharmacokinetics and Pharmacodynamics, 2004,31:157-179.
  • 8Nigrovic V, Amann A. Competition between acetylcholine and a non- depolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block. Journal of Pharmacokinetics and Pharmacodynamics, 2003,30:23-51.
  • 9Jalkanen L, Meretoja OA, Taivainen T, et al. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesth Analg, 1994,79:998-1002.
  • 10Paul M, Kindler CH, Fokt RM, et al. Isobolographic analysis of non-depolarizing muscle relaxant interactions at their receptor site. European Journal of Pharmacology, 2002,438:35-43.

共引文献8

同被引文献37

  • 1上官王宁,连庆泉,陈小玲,李军,Fang Gao Smith.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395-396. 被引量:18
  • 2景金柱,余卫兵,毕雪艳,郭迎霞.HPLC测定麻杏止咳糖浆中盐酸麻黄碱的含量[J].河北医药,2006,28(3):225-226. 被引量:4
  • 3邱郁薇,李士通.非去极化肌松药相互作用的机制及临床应用[J].国际麻醉学与复苏杂志,2007,28(3):250-252. 被引量:9
  • 4张象麟.药物临床信息参考[M].重庆:重庆出版社,2008:674-675.
  • 5De Ruiter J,Crawford MW.Dose-response relationship and infusion requirement of cisatracurium besylate in in-fants and children during nitrous oxide-narcotic anesthesia[J].Anesthesiology,2001,94 (5):790-792.
  • 6Kenaan CA,Estacio RL,Bikhazi GB.Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia[J].Clinical anaesthesiology,2000,12 (3):1731.
  • 7Taivainen T,Meakin GH,Meretoja OA,et al.The safety and efficacy of cisatracurium 0.15mg∕kg during nitrous oxide-opioid anaesthesia in infants and children[J].Anaesthesia,2000,55 (11):1047-1051.
  • 8David FK,Virginia DS.Clinical Pharmacokinetics of Cisatracurium Besilate[J].Clin Pharmacokinet,1999,36 (1):27-40.
  • 9Adams WA,Mark-Senior J,Jones RS,et al.Cisatracurium in dogs with and without porto-systemic shunts[J].Vet-Anaesth-Analg,2006,33 (1):17-23.
  • 10卢慧勤,郭建荣.顺式阿曲库铵药代学和药效学研究进展[C].2008年第七次华东六省一市麻醉学学术会议暨浙江省麻醉学术年会论文汇编(上册),2008.

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部